Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protopic vs Elidel in Pediatric Mild Atopic Dermatitis
NCT00667160Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2002
- Primary completion
- Nov 2003
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Envarsus XR in atopic dermatitis (AD), sponsored by Astellas Pharma. Started Dec 2002; status: completed.
02
Drugs
Envarsus XR
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00667160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667160.